Biotherapeutic Manufacturing Chromatography Market Size is predicted to expand with a 8.9% CAGR during the forecast period for 2025-2034.
"Biotherapeutic manufacturing chromatography" refers to a collection of techniques used in the manufacturing process to separate and purify biotherapeutic products, such as monoclonal antibodies, vaccinations, and gene therapies. Because of the growing need for biotherapeutics such as vaccines, gene and cell treatments, and monoclonal antibodies (mAbs), the market for biotherapeutic manufacturing chromatography is expected to grow rapidly. Furthermore, the market is expanding due to developments and advancements in chromatography technology, increased investments in biologics, and robust regulatory backing for biopharmaceuticals. In addition, Increased automation is anticipated in the industry as AI-powered chromatography systems and continuous bioprocessing technologies proliferate.
Additionally, the need for more specialized chromatographic solutions will increase because of the increased emphasis on precision biologics and precision medicine; next-generation resins and hybrid matrices provide more affordable and scalable alternatives for the manufacturing of biotherapeutics.
• Pall Corporation
• Merck KgaA
• Bio-Rad Laboratories
• Thermo Fisher Scientific
• Purolite
• YMC CO., LTD.
• Repligen Corporation
• Cytiva
• Sartorius
• Agilent Technologies
• Waters Corporation
• Other Market Players
The Biotherapeutic Manufacturing Chromatography market is segmented based on product, type, matrix type, application, and end-user. In the product, the market is segmented into Consumables, Equipment, and Software. By type, the market is segmented into Affinity Chromatography, Ion Exchange Chromatography, Size Exclusion Chromatography, and Hydrophobic Interaction Chromatography. By matrix type, the market is segmented into Polystyrene-Based Matrices, Methacrylate-Based Matrices, Polyacrylamide-Based Matrices, Silica-Based Matrices, and Inorganic Hybrid and Composite Matrices. By application category, the market is segmented into Monoclonal Antibodies (mAbs), Vaccines, Cell & Gene Therapy, and Others. By end-user, the market is segmented into Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), and Academic and Research Institutions.
The consumable category is expected to hold a major global market share in 2024. When it comes to biopharmaceutical purification procedures, consumables such as chromatography resins and buffers are essential. Their frequent use guarantees steady and strong market demand. The increasing research and development efforts in the biotechnology and pharmaceutical industries are the main driver of this expansion since they call for a consistent supply of high-quality consumables for a range of chromatographic procedures. For example, the extensive use of liquid chromatography in quality control and drug development procedures highlights how important consumables are to precise and effective separations.
In large-scale biopharmaceutical purification, polystyrene-based matrices are preferred due to their high binding effectiveness and longevity. These matrices provide a reliable and sturdy basis for a range of chromatographic separations, guaranteeing steady performance even in the most taxing industrial bioprocessing environments. Their chemical compatibility and mechanical strength enable recurrent use, increasing process efficiency and reducing operating expenses. The capacity of polystyrene-based matrices to consistently maintain high product yield and purity is also crucial for fulfilling the exacting quality standards needed in the production of biopharmaceuticals.
The North American Biotherapeutic Manufacturing Chromatography market is expected to register the highest market share in revenue in the near future driven by its advanced research and development (R&D) skills, a supportive regulatory environment, and a well-established biopharmaceutical sector. To assist the development of cutting-edge treatments, major biotech and pharmaceutical companies based in the United States, including Amgen, Pfizer, and Biogen, make significant investments in chromatography-based bioprocessing. Modern biomanufacturing facilities are also available in the area, and contract manufacturing companies (CMOs) like Lonza and Catalent provide specialized services to satisfy the expanding needs of the sector.
In addition, Asia Pacific is projected to grow rapidly in the global Biotherapeutic Manufacturing Chromatography market. As the demand for high-resolution separation techniques continues to develop, the market is seeing a move towards innovative goods and advanced technology. Furthermore, the market for biotherapeutic membrane chromatography is growing in the Asia Pacific region due to strict laws governing drug safety and quality assurance.
|
Report Attribute |
Specifications |
|
Growth Rate CAGR |
CAGR of 8.9% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Mn and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product, Type, Matrix Type, Application, And End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Pall Corporation, Merck KgaA, Bio-Rad Laboratories, Thermo Fisher Scientific, Purolite, YMC CO., LTD., Repligen Corporation, Cytiva, and Others. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Biotherapeutic Manufacturing Chromatography Market Snapshot
Chapter 4. Global Biotherapeutic Manufacturing Chromatography Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.9. Use/impact of AI on Biotherapeutic Manufacturing Chromatography Market Industry Trends
4.10. Global Biotherapeutic Manufacturing Chromatography Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. Biotherapeutic Manufacturing Chromatography Market Segmentation 1: By Product, Estimates & Trend Analysis
5.1. Market Share By Product, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Product Type:
5.2.1. Consumables
5.2.2. Equipment
5.2.3. Software
Chapter 6. Biotherapeutic Manufacturing Chromatography Market Segmentation 2: By Type, Estimates & Trend Analysis
6.1. Market Share By Type, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Source:
6.2.1. Affinity Chromatography
6.2.2. Ion Exchange Chromatography
6.2.3. Size Exclusion Chromatography
6.2.4. Hydrophobic Interaction Chromatography
Chapter 7. Biotherapeutic Manufacturing Chromatography Market Segmentation 3: By Matrix Type, Estimates & Trend Analysis
7.1. Market Share By Matrix Type, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Matrix Type:
7.2.1. By Matrix Type
7.2.2. Polystyrene-Based Matrices
7.2.3. Methacrylate-Based Matrices
7.2.4. Silica-Based Matrices
7.2.5. Polyacrylamide-Based Matrices
7.2.6. Inorganic Hybrid and Composite Matrices
Chapter 8. Biotherapeutic Manufacturing Chromatography Market Segmentation 4: By Application, Estimates & Trend Analysis
8.1. Market Share By Application, 2024 & 2034
8.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
8.2.1. Monoclonal Antibodies (mAbs)
8.2.2. Vaccines
8.2.3. Cell & Gene Therapy
8.2.4. Other Biotherapeutics
Chapter 9. Biotherapeutic Manufacturing Chromatography Market Segmentation 4: By End User, Estimates & Trend Analysis
9.1. Market Share By Application, 2024 & 2034
9.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following End User
9.2.1. Biopharmaceutical Companies
9.2.2. Contract Manufacturing Organizations (CMOs)
9.2.3. Academic and Research Institutions
Chapter 10. Biotherapeutic Manufacturing Chromatography Market Segmentation 5: Regional Estimates & Trend Analysis
10.1. Global Biotherapeutic Manufacturing Chromatography Market, Regional Snapshot 2024 & 2034
10.2. North America
10.2.1. North America Biotherapeutic Manufacturing Chromatography Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.2.1.1. US
10.2.1.2. Canada
10.2.2. North America Biotherapeutic Manufacturing Chromatography Market Revenue (US$ Million) Estimates and Forecasts By Product, 2021-2034
10.2.3. North America Biotherapeutic Manufacturing Chromatography Market Revenue (US$ Million) Estimates and Forecasts By Type, 2021-2034
10.2.4. North America Biotherapeutic Manufacturing Chromatography Market Revenue (US$ Million) Estimates and Forecasts By Matrix Type, 2021-2034
10.2.5. North America Biotherapeutic Manufacturing Chromatography Market Revenue (US$ Million) Estimates and Forecasts By Application, 2021-2034
10.2.6. North America Biotherapeutic Manufacturing Chromatography Market Revenue (US$ Million) Estimates and Forecasts By End User, 2021-2034
10.3. Europe
10.3.1. Europe Biotherapeutic Manufacturing Chromatography Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.3.1.1. Germany
10.3.1.2. U.K.
10.3.1.3. France
10.3.1.4. Italy
10.3.1.5. Spain
10.3.1.6. Rest of Europe
10.3.2. Europe Biotherapeutic Manufacturing Chromatography Market Revenue (US$ Million) Estimates and Forecasts By Product, 2021-2034
10.3.3. Europe Biotherapeutic Manufacturing Chromatography Market Revenue (US$ Million) Estimates and Forecasts By Type, 2021-2034
10.3.4. Europe Biotherapeutic Manufacturing Chromatography Market Revenue (US$ Million) Estimates and Forecasts By Matrix Type, 2021-2034
10.3.5. Europe Biotherapeutic Manufacturing Chromatography Market Revenue (US$ Million) Estimates and Forecasts By Application, 2021-2034
10.3.6. North America Biotherapeutic Manufacturing Chromatography Market Revenue (US$ Million) Estimates and Forecasts By End User, 2021-2034
10.4. Asia Pacific
10.4.1. Asia Pacific Biotherapeutic Manufacturing Chromatography Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.4.1.1. India
10.4.1.2. China
10.4.1.3. Japan
10.4.1.4. Australia
10.4.1.5. South Korea
10.4.1.6. Hong Kong
10.4.1.7. Southeast Asia
10.4.1.8. Rest of Asia Pacific
10.4.2. Asia Pacific Biotherapeutic Manufacturing Chromatography Market Revenue (US$ Million) Estimates and Forecasts By Product, 2021-2034
10.4.3. Asia Pacific Biotherapeutic Manufacturing Chromatography Market Revenue (US$ Million) Estimates and Forecasts By Type, 2021-2034
10.4.4. Asia Pacific Biotherapeutic Manufacturing Chromatography Market Revenue (US$ Million) Estimates and Forecasts By Matrix Type, 2021-2034
10.4.5. Asia Pacific Biotherapeutic Manufacturing Chromatography Market Revenue (US$ Million) Estimates and Forecasts By Application, 2021-2034
10.4.6. North America Biotherapeutic Manufacturing Chromatography Market Revenue (US$ Million) Estimates and Forecasts By End User, 2021-2034
10.5. Latin America
10.5.1. Latin America Biotherapeutic Manufacturing Chromatography Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.5.1.1. Brazil
10.5.1.2. Mexico
10.5.1.3. Rest of Latin America
10.5.2. Latin America Biotherapeutic Manufacturing Chromatography Market Revenue (US$ Million) Estimates and Forecasts By Product, 2021-2034
10.5.3. Latin America Biotherapeutic Manufacturing Chromatography Market Revenue (US$ Million) Estimates and Forecasts By Type, 2021-2034
10.5.4. Latin America Biotherapeutic Manufacturing Chromatography Market Revenue (US$ Million) Estimates and Forecasts By Matrix Type, 2021-2034
10.5.5. Latin America Biotherapeutic Manufacturing Chromatography Market Revenue (US$ Million) Estimates and Forecasts By Application, 2021-2034
10.5.6. North America Biotherapeutic Manufacturing Chromatography Market Revenue (US$ Million) Estimates and Forecasts By End User, 2021-2034
10.6. Middle East & Africa
10.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
10.6.1.1. GCC Countries
10.6.1.2. Israel
10.6.1.3. South Africa
10.6.1.4. Rest of Middle East and Africa
10.6.2. Middle East & Africa Biotherapeutic Manufacturing Chromatography Market Revenue (US$ Million) Estimates and Forecasts By Product, 2021-2034
10.6.3. Middle East & Africa Biotherapeutic Manufacturing Chromatography Market Revenue (US$ Million) Estimates and Forecasts By Type, 2021-2034
10.6.4. Middle East & Africa Biotherapeutic Manufacturing Chromatography Market Revenue (US$ Million) Estimates and Forecasts By Matrix Type, 2021-2034
10.6.5. Middle East & Africa Biotherapeutic Manufacturing Chromatography Market Revenue (US$ Million) Estimates and Forecasts By Application, 2021-2034
10.6.6. North America Biotherapeutic Manufacturing Chromatography Market Revenue (US$ Million) Estimates and Forecasts End User, 2021-2034
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Pall Corporation
11.2.1.1. Business Overview
11.2.1.2. Key Product Type/Service Overview
11.2.1.3. Financial Performance
11.2.1.4. Geographical Presence
11.2.1.5. Recent Developments with Business Strategy
11.2.2. Merck KGaA
11.2.3. Bio-Rad Laboratories
11.2.4. Thermo Fisher Scientific
11.2.5. Cytiva
11.2.6. YMC CO., LTD.
11.2.7. Purolite
11.2.8. Repligen Corporation
11.2.9. Other Players.
Biotherapeutic Manufacturing Chromatography Market By Product-
• Consumables
• Equipment
• Software
Biotherapeutic Manufacturing Chromatography Market By Type-
• Affinity Chromatography
• Ion Exchange Chromatography
• Size Exclusion Chromatography
• Hydrophobic Interaction Chromatography
Biotherapeutic Manufacturing Chromatography Market By Matrix Type-
• Polystyrene-Based Matrices
• Methacrylate-Based Matrices
• Polyacrylamide-Based Matrices
• Silica-Based Matrices
• Inorganic Hybrid and Composite Matrices
Biotherapeutic Manufacturing Chromatography Market By Application-
• Monoclonal Antibodies (mAbs)
• Vaccines
• Cell & Gene Therapy
• Others
Biotherapeutic Manufacturing Chromatography Market By End-user-
• Biopharmaceutical Companies
• Contract Manufacturing Organizations (CMOs)
• Academic and Research Institutions
Biotherapeutic Manufacturing Chromatography Market By Region-
North America-
• The US
• Canada
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Mexico
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
